https://scholars.lib.ntu.edu.tw/handle/123456789/545376
標題: | Time to Colonoscopy and Risk of Colorectal Cancer in Patients With Positive Results From Fecal Immunochemical Tests | 作者: | YI-CHIA LEE Fann J.C.-Y. TSUNG-HSIEN CHIANG Chuang S.-L. Chen S.L.-S. HAN-MO CHIU Yen A.M.-F. Chiu S.Y.-H. Hsu C.-Y. WEN-FENG HSU MING-SHIANG WU Chen, Tony Hsiu Hsi |
公開日期: | 2019 | 出版社: | W.B. Saunders | 卷: | 17 | 期: | 7 | 起(迄)頁: | 1332-1340.e3 | 來源出版物: | Clinical Gastroenterology and Hepatology | 摘要: | Background & Aims: In patients with positive results from a fecal immunochemical test (FIT), failure to receive a timely follow-up colonoscopy may be associated with higher risks of colorectal cancer (CRC) and advanced-stage CRC. We evaluated the prevalence of any CRC and advanced-stage CRC associated with delays in follow-up colonoscopies for patients with positive results from a FIT. Methods: We collected data from 39,346 patients (age, 50–69 years) who participated in the Taiwanese Nationwide Screening Program from 2004 through 2012 and had completed a colonoscopy more than 1 month after a positive result from a FIT. Risks of any CRC and advanced-stage CRC (stage III-IV) were evaluated using logistic regression models and results expressed as adjusted odds ratios (aORs) and corresponding 95% CIs. Results: In our cohort, 2003 patients received a diagnosis of any CRC and 445 patients were found to have advanced-stage disease. Compared with colonoscopy within 1–3 months (cases per 1000 patients: 50 for any CRC and 11 for advanced-stage disease), risks were significantly higher when colonoscopy was delayed by more than 6 months for any CRC (aOR, 1.31; 95% CI, 1.04–1.64; 68 cases per 1000 patients) and advanced-stage disease (aOR, 2.09; 95% CI, 1.43–3.06; 24 cases per 1000 patients). The risks continuously increased when colonoscopy was delayed by more than 12 months for any CRC (aOR, 2.17; 95% CI, 1.44–3.26; 98 cases per 1000 patients) and advanced-stage disease (aOR, 2.84; 95% CI, 1.43–5.64; 31 cases per 1000 patients). There were no significant differences for colonoscopy follow up at 3–6 months for risk of any CRC (aOR, 0.98; 95% CI, 0.86–1.12; 49 cases per 1000 patients) or advanced-stage disease (aOR, 0.95; 95% CI, 0.72–1.25; 10 cases per 1000 patients). Conclusions: In an analysis of data from the Taiwanese Nationwide Screening Program, we found that among patients with positive results from a FIT, risks of CRC and advanced-stage disease increase with time. These findings indicate the importance of timely colonoscopy after a positive result from a FIT. ? 2019 AGA Institute |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065764779&doi=10.1016%2fj.cgh.2018.10.041&partnerID=40&md5=6470cb4f07fb8ef79077adec9c53b53d https://scholars.lib.ntu.edu.tw/handle/123456789/545376 |
ISSN: | 1542-3565 | DOI: | 10.1016/j.cgh.2018.10.041 | SDG/關鍵字: | adult; advanced cancer; aged; Article; cancer risk; cancer staging; clinical evaluation; cohort analysis; colonoscopy; colorectal cancer; disease association; disease course; feces analysis; female; follow up; human; immunochemistry; major clinical study; male; risk assessment; risk factor; chemistry; clinical trial; colonoscopy; colorectal tumor; feces; immunohistochemistry; incidence; mass screening; metabolism; middle aged; multicenter study; procedures; retrospective study; Taiwan; time factor; tumor marker; Aged; Biomarkers, Tumor; Colonoscopy; Colorectal Neoplasms; Feces; Female; Follow-Up Studies; Humans; Immunohistochemistry; Incidence; Male; Mass Screening; Middle Aged; Retrospective Studies; Taiwan; Time Factors |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。